Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30

By sjmartinez • November 20, 2022

Henry NL, Kim S, Hays RD, Diniz MA, Tighiouart M, Gresham G, Luu M, Cecchini RS, Yothers G, Rogatko A, Ganz PA. Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30. NPJ Breast Cancer. 2022 Nov 19;8(1):123. doi: 10.1038/s41523-022-00489-9. PMID: 36402796; PMCID: PMC9675799.

Tags: Cedars Sinai DoM, Hematology/Oncology, Publications

LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes

Ding J, Nguyen AT, Lohman K, Hensley MT, Parker D, Hou L, Taylor J, Voora D, Sawyer JK, Boudyguina E, Bancks MP, Bertoni A, Pankow[...]

Pharmacist, nurse, and physician perspectives on the implementation of the pharmacist discharge care (pharm-dc) intervention: A qualitative study

Oche O, Murry LT, Keller MS, Pevnick JM, Schnipper JL, Nguyen AT, Ko EM, Kennelty KA. Pharmacist, nurse, and physician perspectives on the implementation of[...]

Role of biomarkers in the diagnosis and management of HCC

Alhasan M, Mehta N, Yang JD, Singal AG. Role of biomarkers in the diagnosis and management of HCC. Liver Transpl. 2024 May 14. doi: 10.1097/LVT.0000000000000398.[...]